The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II trial of cabozantinib combined with PD-1 and CTLA-4 inhibition versus cabozantinib in metastatic soft tissue sarcoma.
 
Brian Andrew Van Tine
Leadership - Polaris
Honoraria - Bionest Partner; Horizon CME; Research to Practice; Targeted Oncology
Consulting or Advisory Role - Adaptimmune; ADRx; Apexigen; Ayala Pharmaceuticals; Bayer; Boehringer Ingelheim; Cytokinetics; Daiihi Sankyo; Deciphera; EcoR1 Capital; EcoR1 Capital; EMD Serono; Epizyme; GlaxoSmithKline; Immune Design; Intellisphere; Lilly; Novartis; Pfizer; PTC Therapeutics
Speakers' Bureau - Adaptimmune; GlaxoSmithKline; Lilly; Novartis
Research Funding - GlaxoSmithKline; Merck; Pfizer; TRACON Pharma
Patents, Royalties, Other Intellectual Property - Accuronix Therapeutics- Licensing agreement. Sigma-2 Receptor Ligands and Therapeutic uses therefor (006766), • Modular Platform for Targeted Therapeutic Delivery (006755), • Sigma-2 Receptor Ligand Drug Conjugates as Antitumor Compounds, Methods of synth; Patent on ALEXT3102; Patent on the use of ME1 as a biomarker
Expert Testimony - Health Advances
Travel, Accommodations, Expenses - Adaptimmune; Advenchen Laboratories; GlaxoSmithKline; Lilly
 
Vanessa Eulo
No Relationships to Disclose
 
Jacqui Toeniskoetter
No Relationships to Disclose
 
Tyler Ruff
No Relationships to Disclose
 
Jingqin Luo
No Relationships to Disclose
 
Lindsey Kemp
No Relationships to Disclose
 
Cristiam Moreno Tellez
No Relationships to Disclose
 
Mia C. Weiss
No Relationships to Disclose
 
Angela C. Hirbe
Honoraria - Empartners
Consulting or Advisory Role - Alexion Pharmaceuticals; AstraZeneca; Intellisphere, LLC; SpringWorks Therapeutics
Research Funding - Tango Therapeutics
Patents, Royalties, Other Intellectual Property - Boehringer Ingelheim RCV GmBH & Co KG- Licensing- T-019044 Development of a Preclinical NF1-MPNST Platform Suitable for Precision Oncology Drug Discovery and Evaluation. Royalities paid through the University; Deutsches Krebsforschungszentrum-licensing agreement for PDX cell lines. Paid through the University. (Inst)
Travel, Accommodations, Expenses - Alexion Pharmaceuticals; SpringWorks Therapeutics
 
Christian Frederick Meyer
Consulting or Advisory Role - Adaptimmune; BioAtla; Deciphera
Patents, Royalties, Other Intellectual Property - UpToDate
Travel, Accommodations, Expenses - Deciphera
 
Anthony D. Elias
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Agilent; Alexion Pharmaceuticals; Align Oncology; Allergan; Amgen; Biogenerix; Bristol-Myers Squibb; Cigna; Exact Sciences; Gilead Sciences; Illumina; Lilly; Merck; Pfizer; United Health Group
Research Funding - Astellas Pharma (Inst); BioAtla (Inst); Deciphera (Inst); Genentech (Inst); Infinity Pharmaceuticals (Inst); Karyopharm Therapeutics (Inst); Orinove (Inst); TopAlliance BioSciences Inc (Inst); xencor (Inst)
(OPTIONAL) Uncompensated Relationships - Seiyax
 
Mark Diamond
No Relationships to Disclose
 
Lee P. Hartner
No Relationships to Disclose
 
Nam Bui
Consulting or Advisory Role - Rain Therapeutics; SpringWorks Therapeutics
 
Kristen N. Ganjoo
Consulting or Advisory Role - Deciphera; Foundation Medicine
 
Robert G. Maki
Employment - PEEL Therapeutics
Consulting or Advisory Role - Bayer; Deciphera; Ipsen; PEEL Therapeutics; UpToDate
Speakers' Bureau - MJH Life Sciences
Research Funding - Amgen (Inst); Astex Pharmaceuticals (Inst); Bayer (Inst); BioAtla (Inst); Boehringer Ingelheim (Inst); C4 Therapeutics (Inst); Daiichi (Inst); Exelixis (Inst); InhibRx (Inst); PEEL Therapeutics (Inst); Presage Biosciences (Inst); Rain Therapeutics (Inst); Regeneron (Inst); Regeneron (Inst); SARC: Sarcoma Alliance for Research though Collaboration (Inst); SpringWorks Therapeutics (Inst); SynOx (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Uptodate: I write and edit chapters for their online text book.
 
Breelyn A. Wilky
Consulting or Advisory Role - Adaptimmune; Adcendo; Boehringer Ingelheim; Daiichi Sankyo; Deciphera; Epizyme; Polaris; SpringWorks Therapeutics
Research Funding - Agenus; Exelixis
Travel, Accommodations, Expenses - Adaptimmune; Daiichi Sankyo; Deciphera